Kusuri No Aoki Holdings Co., Ltd. (TYO:3549)
3,961.00
-2.00 (-0.05%)
Oct 24, 2025, 3:30 PM JST
Kusuri No Aoki Holdings Revenue
Kusuri No Aoki Holdings had revenue of 139.74B JPY in the quarter ending August 20, 2025, with 16.12% growth. This brings the company's revenue in the last twelve months to 520.87B, up 15.81% year-over-year. In the fiscal year ending May 20, 2025, Kusuri No Aoki Holdings had annual revenue of 501.47B with 14.79% growth.
Revenue (ttm)
520.87B
Revenue Growth
+15.81%
P/S Ratio
0.74
Revenue / Employee
92.57M
Employees
5,627
Market Cap
387.36B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 20, 2025 | 501.47B | 64.60B | 14.79% |
| May 20, 2024 | 436.88B | 58.00B | 15.31% |
| May 20, 2023 | 378.87B | 50.54B | 15.39% |
| May 20, 2022 | 328.34B | 22.46B | 7.34% |
| May 20, 2021 | 305.88B | 5.71B | 1.90% |
| May 20, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 20, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 20, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 20, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.48T |
| Otsuka Holdings | 2.40T |
| Astellas Pharma | 1.94T |
| Daiichi Sankyo Company | 1.92T |
| Chugai Pharmaceutical | 1.20T |
| Terumo | 1.04T |
| Olympus | 969.02B |
| HOYA Corporation | 876.09B |